Company Profile
  • Company Profile
  • Management Team
  • SAB
  • Vision & Mission
  • Milestones
  • Investors

  • SIMR is an innovation-oriented biopharmaceutical company dedicated to the discovery and development of new drugs for pain, inflammation and central nervous system related diseases. Since its establishment in 2014, the company has established a research and development platform of more than 3,000 square meters, with comprehensive drug development capabilities such as compound screening, CMC research, preclinical evaluation, and clinical development.